Number of children who started the trial | 76 |
---|---|
Number of children who completed the trial | 60 |
Mean (SD) | |
Age (yr) | 8.4 (1.0) |
Weight (kg) | 32 (18) |
Height (cm) | 124 (21) |
BMI (kg/m2) | 17.2 (1.3) |
No. of children | |
Boys/Girls | 38/22 |
Urban/Rural | 34/26 |
Associated nasal allergy | 12 |
Asthma medications: | |
Long acting β2-agonist alone | 0 |
Moderate daily dose inhaled corticosteroid | 16 |
Long acting β2-agonist + inhaled corticosteroid | 20 |
β2-agonist + inhaled corticosteroid + intermittent short acting β2-agonist | 18 |
β2-agonist + inhaled corticosteroid + sodium cromoglycate | 6 |
Allergy medications: | |
Antihistamine | 24 |
Intermittent nasal decongestant | 24 |
Nasal corticosteroid | 16 |